Ads
related to: keytruda cancer drug- Contact Us
Have Questions? Don’t Hesitate.
Contact Us Today.
- Precision Oncology
Finding Cancer's Fingerprint.
Learn More.
- NRG1 Fusion
More Aggressive Than You Think.
Learn About NGR1 Today.
- Genomic Landscape
Genomics are Changing the Future
of Oncology. Learn More.
- Contact Us
Search results
Merck is spending $3 billion on an eye drug developer as it braces to lose a key cancer patent
Quartz· 10 hours agoPharma giant Merck said on Wednesday that it is acquiring the privately-held eye drug developer...
Merck's Multi-Billion Cancer Drug Keytruda Aces Late-Stage Breast Cancer Study (UPDATED)
Benzinga via Yahoo Finance· 1 day agoTuesday, Merck & Co Inc (NYSE:MRK) released topline data from hase 3 KEYNOTE-522 trial of Keytruda...
Merck eyes purchase of ophthalmology company
WFMZ Eastern Pennsylvania and Western New Jersey· 3 hours agoTake Merck, for example. Its blockbuster cancer drug, Keytruda, is now the largest selling drug in the world. In the ...
FDA sets review date for Merck's KEYTRUDA in mesothelioma treatment By Investing.com
Investing.com· 7 hours agoMerck & Co., Inc., a global healthcare leader, has announced that the U.S. Food and Drug...
Merck to buy eye-focused drug developer EyeBio for as much as $3 billion
CNBC· 13 hours agoMerck said in February it was in the market for deals of up to $15 billion, and has already struck...
Merck Reaches $1.3 Billion Deal for Eye-Drug Company EyeBio
The Wall Street Journal· 13 hours agoIn recent years, Chief Executive Rob Davis has been doing deals to lessen Merck’s reliance on the...
ASCO 2024: Rakuten’s photoimmunotherapy and Keytruda combo shows efficacy in HNSCC
Clinical Trials Arena via Yahoo Finance· 1 day agoThis potentially causes membrane damage in cancer cells, leading to selective necrosis of cancer...
BMS secures another EC approval for Opdivo combination
Pharmaceutical Technology via Yahoo Finance· 11 hours agoThe decision follows a US Food and Drug Administration (FDA) approval for the Opdivo combination...
Merck to Buy Eye Drug Company Eyebiotech for Up to $3 Billion. It’s Doubling Down on Deals.
Barrons.com· 12 hours agoThe pharmaceutical company agrees to buy eye drug company Eyebiotech for up to $3 billion as it...
Merck Reportedly Nearing $1.3B Acquisition Of EyeBio To Expand Eye-Care Market Presence - Merck & Co...
Benzinga· 16 hours agoMerck & Co., Inc. MRK is reportedly on the verge of acquiring EyeBio, an eye drug company, for a sum...
Ads
related to: keytruda cancer drug
